Study of Immune Globulin Intravenous (Human) GC5107 in Subjects With Primary Humoral Immunodeficiency
Public ClinicalTrials.gov record NCT02783482. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-Label, Single-Arm, Historically Controlled, Prospective, Multicenter Phase III Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Immune Globulin Intravenous (Human) GC5107 in Subjects With Primary Humoral Immunodeficiency
Study identification
- NCT ID
- NCT02783482
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Green Cross Corporation
- Industry
- Enrollment
- 49 participants
Conditions and interventions
Conditions
Interventions
- GC5107 Biological
Biological
Eligibility (public fields only)
- Age range
- 2 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 30, 2016
- Primary completion
- Jun 30, 2019
- Completion
- Jun 30, 2019
- Last update posted
- Dec 8, 2022
2016 – 2019
United States locations
- U.S. sites
- 10
- U.S. states
- 7
- U.S. cities
- 9
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Immuno International Research Centers | Centennial | Colorado | 80112 | — |
| Allergy Associates of Palm Beaches PA | North Palm Beach | Florida | 33408 | — |
| Midwest Immunology Clinic and Infusion Center | Plymouth | Minnesota | 55446 | — |
| Optimed Infusions LLC | Columbus | Ohio | 43235 | — |
| Oklahoma Institute of Allergy Ashma and Immunology | Oklahoma City | Oklahoma | 73131 | — |
| Allergy Partners of North Texas Research | Dallas | Texas | 75230 | — |
| Allergy and Asthma Specialists | Dallas | Texas | 75231 | — |
| Pediatric Pulmonary Associates of North Texas | Frisco | Texas | 75034 | — |
| Allergy Asthma and Immunology Clinic PA | Irving | Texas | 75063 | — |
| Lysosomal Rare Disorder Research and Treatment Center, Inc. | Fairfax | Virginia | 22030 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 10 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02783482, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 8, 2022 · Synced Jun 26, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02783482 live on ClinicalTrials.gov.